Industry News: "Understanding Cancer Immunotherapy"

Even though the study of immunotherapy has been around for more than a century, its value to the treatment of cancer is greater today than ever. Drug development is progressing rapidly, data from clinical trials continues to impress, and, most important, more and more patients are experiencing remarkable responses to these treatments that allow them to lead longer, healthier lives.